These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 24357676

  • 1. The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients.
    Burakgazi E, Bashir S, Doss V, Pellock J.
    Clin EEG Neurosci; 2014 Apr; 45(2):89-91. PubMed ID: 24357676
    [Abstract] [Full Text] [Related]

  • 2. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL, Wang YY, Cook MJ, Murphy MA, D'Souza WJ.
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous levetiracetam in clinical practice--Results from an independent registry.
    Lang N, Esser W, Evers S, Kellinghaus C, Nguento A, Schlegel U, Gaida B, Gburek-Augustat J, Altenmüller DM, Burghaus L, Hoffmann F, Fiedler B, Bast T, Rehfeld T, Happe S, Seitz RJ, Boor R, Stephani U.
    Seizure; 2015 Jul; 29():109-13. PubMed ID: 26076852
    [Abstract] [Full Text] [Related]

  • 5. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF, Crisp ED, Kayani S, Rajab H.
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of levetiracetam for critically ill patients with seizures.
    Nau KM, Divertie GD, Valentino AK, Freeman WD.
    Neurocrit Care; 2009 Jul; 11(1):34-7. PubMed ID: 19184555
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT, Hastriter EV, Cardenas JF, Khoury EM, Chapman KE.
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [Abstract] [Full Text] [Related]

  • 12. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 13. The use of levetiracetam in refractory status epilepticus.
    Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN.
    Seizure; 2006 Apr; 15(3):137-41. PubMed ID: 16426869
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE, Yuksel Karatoprak E, Yilmaz S.
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [Abstract] [Full Text] [Related]

  • 15. A Comparison of Intravenous Levetiracetam and Valproate for the Treatment of Refractory Status Epilepticus in Children.
    İşgüder R, Güzel O, Ceylan G, Yılmaz Ü, Ağın H.
    J Child Neurol; 2016 Aug; 31(9):1120-6. PubMed ID: 27080042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.